French health insurer Malakoff Humanis is under a financial prosecutor’s corruption probe over intermediary payments linked to its listed and unlisted investments
Executive summary: French prosecutors launched a corruption inquiry into Malakoff Humanis concerning intermediary fees paid on its investment portfolio. The investigation raises governance and compliance risks for a major health insurer, potentially leading to financial penalties, stricter oversight, and erosion of client trust. Malakoff Humanis, the Parquet national financier (France’s financial prosecutor), and unidentified intermediaries linked to the insurer’s listed and unlisted investments. Further evidence gathering, possible formal charges, internal audits by Malakoff Humanis, and potential guidance from French insurance regulators on intermediary remuneration.
The Parquet national financier has opened an investigation into Malakoff Humanis focusing on the remuneration of intermediaries for both listed and unlisted assets. The probe examines whether improper payments were made to third parties involved in the insurer’s investment activities. If substantiated, the case could trigger fines, compliance overhauls, and reputational damage for one of France’s leading complementary health providers. The development adds to growing regulatory scrutiny of incentive structures in the French insurance and asset‑management sectors.
Open the full case file on Beyond →
INTELLIGENCE
Social Pulse
AI estimate · not scraped